{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T22:05:56Z","timestamp":1696197956895},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T00:00:00Z","timestamp":1285804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00066-010-2121-6","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T16:51:35Z","timestamp":1286988695000},"page":"572-579","source":"Crossref","is-referenced-by-count":16,"title":["Helical Tomotherapy in Cervical Cancer Patients"],"prefix":"10.1007","volume":"186","author":[{"given":"Simone","family":"Marnitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Stromberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kawgan-Kagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"Wlodarczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Budach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christhardt","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,30]]},"reference":[{"key":"2121_CR1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0360-3016(01)01820-X","volume":"52","author":"Baglan","year":"2002","unstructured":"Baglan KL, Frazier RC, Yan D, et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2002;52: 176\u201383","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2121_CR2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/gyno.2000.5860","volume":"78","author":"Bodurka-Bevers","year":"2000","unstructured":"Bodurka-Bevers D, Morris M, Eifel PJ, et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol 2000;78:187\u201393","journal-title":"Gynecol Oncol"},{"key":"2121_CR3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/BF03038982","volume":"174","author":"Chatani","year":"1998","unstructured":"Chatani M, Nose T, Masaki N, Inoue T. Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Strahlenther Onkol 1998;174:504\u20139","journal-title":"Strahlenther Onkol"},{"key":"2121_CR4","doi-asserted-by":"crossref","unstructured":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802\u201312","DOI":"10.1200\/JCO.2008.16.4368"},{"key":"2121_CR5","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ijrobp.2006.11.005","volume":"67","author":"Chen","year":"2007","unstructured":"Chen MF, Tseng CJ, Tseng CC, et al. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent cisplatin and intensity- modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1438\u201344","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2121_CR6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/PPO.0b013e318173a04b","volume":"14","author":"Chen","year":"2008","unstructured":"Chen MF, Tseng CJ, Tseng CC, et al. Adjuvant concurrent chemoradiotherapy with intensity modulated pelvic radiotherapy after surgery for high risk, early stage cervical cancer patents. J Cancer 2008;14:200\u20136","journal-title":"J Cancer"},{"key":"2121_CR7","unstructured":"Common Terminology Criteria for Adverse Events v3.0, CTCAE v3.0 (http:\/\/ ctep.cancer.gov)"},{"key":"2121_CR8","unstructured":"Diagnostik und Therapie des Zervixkarzinoms. Interdisziplin\u00e4re Leitlinie der Deutschen Krebsgesellschaft e.V. (DKG) und der Deutschen Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe (DGGG). Algorithmus 5 (http:\/\/www.awmf.de)"},{"key":"2121_CR9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00066-009-1918-7","volume":"185","author":"Dimopoulos","year":"2009","unstructured":"Dimopoulos JC, Schirl G, Baldinger A, et al. MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol 2009;185:282\u20137","journal-title":"Strahlenther Onkol"},{"key":"2121_CR10","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.ijrobp.2008.10.017","volume":"74","author":"Engels","year":"2009","unstructured":"Engels B, de Ridder M, Tournel K, et al. Preoperative helical tomography and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowel. Int J Radiat Oncol Biol Phys 2009;74: 1476\u201380","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2121_CR11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00066-008-1872-9","volume":"184","author":"Georg","year":"2008","unstructured":"Georg D, Georg D, Hillbrand M, et al. Assessment of improved organ at risk sparing for advanced cervix carcinoma utilizing precision radiotherapy techniques. Strahlenther Onkol 2008;184:586\u201391","journal-title":"Strahlenther Onkol"},{"key":"2121_CR12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(01)05965-7","volume":"358","author":"Green","year":"2001","unstructured":"Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy an radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781\u20136","journal-title":"Lancet"},{"key":"2121_CR13","unstructured":"http:\/\/www.rtog.org"},{"key":"2121_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00066-002-0914-y","volume":"178","author":"H\u00e4nsgen","year":"2002","unstructured":"H\u00e4nsgen G, Kuhnt T, Pigorsch S, et al. Adjuvante simultane Radiochemotherapie nach operiertem Uteruszervixkarzinom in der High-Risk-Situation. Ergebnisse einer Pilotuntersuchung. Strahlenther Onkol 2002;178:71\u20137","journal-title":"Strahlenther Onkol"},{"key":"2121_CR15","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","volume":"340","author":"Keys","year":"1999","unstructured":"Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154\u201361","journal-title":"N Engl J Med"},{"key":"2121_CR16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0167-8140(03)00197-X","volume":"68","author":"Kirwan","year":"2003","unstructured":"Kirwan JM, Symonds P, Green JA, et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003;68:217\u201326","journal-title":"Radiother Oncol"},{"key":"2121_CR17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijrobp.2007.10.021","volume":"70","author":"Lian","year":"2008","unstructured":"Lian J, Mackenzie M, Joseph K, et al. Assessment of extended field radiotherapy for stage IIIC endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy and helical tomotherapy. Int J Radiat Oncol Biol Phys 2008;70:935\u201343","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2121_CR18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ygyno.2005.07.005","volume":"99","author":"Marnitz","year":"2005","unstructured":"Marnitz S, K\u00f6hler C, Roth C, et al. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol 2005;99:536\u201344","journal-title":"Gynecol Oncol"},{"key":"2121_CR19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00066-007-1675-4","volume":"183","author":"Marnitz","year":"2007","unstructured":"Marnitz S, K\u00f6hler C, Roth C, et al. Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging. Strahlenther Onkol 2007;183:473\u20138","journal-title":"Strahlenther Onkol"},{"key":"2121_CR20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","volume":"340","author":"Morris","year":"1999","unstructured":"Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137\u201343","journal-title":"N Engl J Med"},{"key":"2121_CR21","first-page":"446","volume":"82","author":"Mundt","year":"2001","unstructured":"Mundt AJ, Roeske JC, Lujan AE, et al. Initial clinical experience with intensity- modulated whole pelvis radiation therapy in patients with gynaecologic malignancies. Gynecol Oncol 2001;82:446\u201356","journal-title":"Gynecol Oncol"},{"key":"2121_CR22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00066-009-1893-z","volume":"185","author":"Nagy","year":"2009","unstructured":"Nagy V, Coza O, Ordeanu C, et al. Radiotherapy versus concurrent 5-day cisplatin and radiotherapy in locally advanced cervical carcinoma. Long-term results of a phase III randomized trial. Strahlenther Onkol 2009;185: 177\u201383","journal-title":"Strahlenther Onkol"},{"key":"2121_CR23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0360-3016(99)00111-X","volume":"44","author":"Perez","year":"1999","unstructured":"Perez CA, Grigsby PW, Locket MA, et al. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 1999;44:855\u201366","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2121_CR24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0360-3016(01)01664-9","volume":"51","author":"Portelance","year":"2001","unstructured":"Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum and bladder doses in patients with cervical cancer receiving pelvic and paraaortic radiation. Int J Radiat Biol Oncol Phys 2001;51:261\u20136","journal-title":"Int J Radiat Biol Oncol Phys"},{"key":"2121_CR25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.semradonc.2006.02.002","volume":"16","author":"Randall","year":"2006","unstructured":"Randall ME, Ibbott GS. Intensity-modulated radiation therapy (IMRT) for gynaecologic cancers. Pitfalls, hazards, and cautions to be considered. Semin Radiat Oncol 2006;16:138\u201343","journal-title":"Semin Radiat Oncol"},{"key":"2121_CR26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijrobp.2007.06.066","volume":"70","author":"Robertson","year":"2008","unstructured":"Robertson JM, Lockman D, Yan D, et al. The doses-volume relationship of small bowel irradiation and acute grade 3 diarrhoea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2008;70:413\u20138","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2121_CR27","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0360-3016(00)00771-9","volume":"48","author":"Roeske","year":"2000","unstructured":"Roeske JC, Lujan A, Rotmensch J, et al. Intensity modulated whole pelvis therapy in patients with gynaecologic malignancies. Int J Radiat Oncol Biol Phys 2000;48:1613\u201321","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2121_CR28","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","volume":"340","author":"Rose","year":"1999","unstructured":"Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144\u201353","journal-title":"N Engl J Med"},{"key":"2121_CR29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ygyno.2007.07.025","volume":"107","author":"Sartori","year":"2007","unstructured":"Sartori E, Pasinetti B, Carrara L, et al. Pattern of failure and value of follow- up procedures in endometrial and cervical cancer patients. Gynecol Oncol 2007;107:241\u20137","journal-title":"Gynecol Oncol"},{"key":"2121_CR30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00066-002-0956-1","volume":"178","author":"Strauss","year":"2002","unstructured":"Strauss HG, Kuhnt T, Laban C, et al. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study. Strahlenther Onkol 2002;178:278\u201385","journal-title":"Strahlenther Onkol"},{"key":"2121_CR31","unstructured":"Uterus-11-Studie der ARO\/AGO. Prospektive, randomisierte und multizentrische Therapieoptimierungsstudie zur Untersuchung des Einflusses des operativen Stagings auf die Wahl der Therapie und die onkologischen Ergebnisse bei Patientinnen mit Zervixkarzinom der FIGO-Stadien IIB\u2013IV (http:\/\/www.degro.org, http:\/\/www.ago.de)"},{"key":"2121_CR32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0360-3016(96)00601-3","volume":"37","author":"van\u2019t Rie","year":"1997","unstructured":"van\u2019t Riet A, Mak AC, Moerland MA, et al. A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys 1997;37:731\u20136","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2121_CR33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00066-009-1986-8","volume":"185","author":"Vandecasteele","year":"2009","unstructured":"Vandecasteele K, De Neve W, De Gersem W, et al. Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Strahlenther Onkol 2009;185:799\u2013807","journal-title":"Strahlenther Onkol"},{"key":"2121_CR34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00066-008-1814-6","volume":"184","author":"Vorwerk","year":"2008","unstructured":"Vorwerk H, Wagner D, Christiansen H, et al. An easy irradiation technique (partial half-beam) to reduce renal dose in radiotherapy of cervical cancer including paraaortic lymph nodes. Strahlenther Onkol 2008;184:473\u20137","journal-title":"Strahlenther Onkol"},{"key":"2121_CR35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00066-009-2028-2","volume":"185","author":"Vorwerk","year":"2009","unstructured":"Vorwerk H, Wagner D, Seitz B, et al. Overestimation of low-dose radiation in intensity-modulated radiotherapy with sliding-window technique. Strahlenther Onkol 2009;185:821\u20139","journal-title":"Strahlenther Onkol"},{"key":"2121_CR36","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","volume":"17","author":"Whitney","year":"1999","unstructured":"Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as adjunct to radiation therapy in stage IIB\u2013IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecology Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339\u201348","journal-title":"J Clin Oncol"},{"key":"2121_CR37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/IGC.0b013e31819c9ffd","volume":"19","author":"Zanagnolo","year":"2009","unstructured":"Zanagnolo V, Ming L, Gadducci A, et al. Surveillance procedures for patients with cervical carcinoma: a review of the literature. Int J Gynecol Cancer 2009;19:194\u2013201","journal-title":"Int J Gynecol Cancer"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2121-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-010-2121-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2121-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:30:58Z","timestamp":1558578658000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-010-2121-6"}},"subtitle":["Simultaneous Integrated Boost Concept: Technique and Acute Toxicity"],"short-title":[],"issued":{"date-parts":[[2010,9,30]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["2121"],"URL":"https:\/\/doi.org\/10.1007\/s00066-010-2121-6","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,30]]}}}